Prothrombotic states associated with retinal venous occlusion in young adults

International Ophthalmology

Volumn 20, Issue 4, 1996, Pages 197-204

  Abu El Asrar, Ahmed M ^a   Al Momen, Abdul Kareem ^a   Al Amro, Saleh ^a   Abdel Gader, Abdel Galil M ^a   Tabbara, Khalid F ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

anticoagulant system; antiphospholipid antibodies; blood viscosity; factor XII; retinal vein occlusion; young adults

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 12; FIBRINOGEN; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S;

ADULT; ARTICLE; BLOOD VISCOSITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; RETINA VEIN OCCLUSION;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, ANTIPHOSPHOLIPID; BLOOD PROTEINS; FEMALE; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; HUMANS; IMMUNOELECTROPHORESIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINAL VEIN OCCLUSION; RISK FACTORS; THROMBOSIS;

EID: 0030425308     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Hayreh SS, Zimmerman MB, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 1994; 117-429-41.
2. Priluck IA, Robertson DM, Hollenhorst RW. Long-term follow-up of occlusion of the central retinal vein in young adults. Am J Ophthalmol 1980; 190-202.
3. Fong ACO, Schatz H, McDonald HR et al. Central retinal vein occlusionin young adults (papillophlebitis). Retina 1991; 11: 3-11.
4. Gupta A, Agarwal A, Bansal RK et al. Ischemic central vein occlusion in the young. Eye 1993; 7: 138-42.
5. Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: A prospective histopathologic study of 29 eyes in 28 cases. Retina 1981; 1: 27-55.
6. Frangieh GT, Green WR, Barraquer-Somers E, Finkelstein D. Histopathologic study of nine branch retinal vein occlusions. Arch Ophthalmol 1982; 100: 1132-40.
7. Virchow R. Phlogose und Thrombose. In: Gesammelte Abhandlunger zur Wissenschaftlichen Medizin. Van Meidlinger Sohn, Frankfurt, pp 458-636, Frankfurt.
8. Bick RL, Pegram M. Syndromes of hypercoagulability and thrombosis: A review. Semin Thromb Hemost 1994; 20: 109-32.
9. Trope GE, Lowe GDO, McArdle BM et al. Abnormal blood viscosity and haemostasis in long-standing retinal vein occlusion. Br J Ophthalmol 1983; 67: 137-42.
10. Peduzzi M, Codeluppi L, Poggi M, Baraldi P. Abnormal blood viscosity and erythrocyte deformability in retinal vein occlusion. Am J Ophthalmol 1983; 96: 399-400.
11. Exner T, Rickard KA, Kroneberg H. A sensitive test demonstrating lupus anticoagulant and its behavioral pattern. Br J Haematol 1978; 40: 143-51.
12. Thiagarajan P, Pengo V, Shapiro SS. The use of the dilute Rusel viper venom time for the diagnosis of lupus anticoagulants. Blood 1986; 68: 869-74.
13. Triplett DA, Brandt JT, Kaczor D, Schaeffer J. Laboratory diagnosis of lupus inhibition: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neuralization procedure. Am J Clin Pathol 1983; 79: 678-82.
14. Abildgaard U, Lie M, Odegard OR. Antithrombin (heparin cofactor) assay with 'new' chromatogenic substrates (S-2238 and chromozym 'TH'). Thromb Res 1977; 11: 549-53.
15. Bick RL, Baker WE Antiphospholipid and thrombosis syndromes. Semin Thromb Hemost 1994; 20: 3-15.
16. Asherson RA, Harris EN. Anticardiolipin antibodies-clinical associations. Postgrad Med J 1986; 62: 1081-7.
17. Asherson RA, Merry P, Acheson JF et al. Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome. Ann Rheum Dis 1989; 48: 358-61.